Company Description

NewGenIvf Group Limited provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, and Kyrgyzstan.

Its services includes mitochondrial replacement (MRT) therapy in reproductive, intrauterine insemination, mrt techniques, in-vitro fertilization /ICSI, hysteroscopy, semen analysis, TESE/TESA/PESA, embryo transfer, egg freezing, and chromosome screening, as well as surrogacy and ancillary caring services.

The company was founded in 2010 and is based in Bangkok, Thailand.

NewGenIvf Group Limited

Country	Thailand
Founded	2011
Industry	Medical - Healthcare Plans
Sector	Healthcare
Employees	70
CEO	Wing Fung Siu

Contact Details

Address: 36/39-36/40, PS Tower, 13th Floor Bangkok, 10110 Thailand
Website	newgenivf.com

Stock Details

Ticker Symbol	NIVF
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	0001981662
ISIN Number	VGG0544E1051
SIC Code	8090

Key Executives

Name	Position
Wing Fung Siu	Chief Executive Officer
Wai Yip Chiu	Chief Financial Officer

Latest SEC Filings

Date	Type	Title
Nov 18, 2024	6-K	Report of foreign issuer
Nov 15, 2024	6-K	Report of foreign issuer
Nov 13, 2024	SC 13G	Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024	424B3	Prospectus
Nov 6, 2024	EFFECT	Notice of Effectiveness
Nov 1, 2024	F-1/A	[Amend] Registration statement for certain foreign private issuers
Oct 25, 2024	F-1/A	[Amend] Registration statement for certain foreign private issuers
Oct 16, 2024	F-1/A	[Amend] Registration statement for certain foreign private issuers
Oct 10, 2024	SC 13G	Statement of acquisition of beneficial ownership by individuals
Sep 30, 2024	F-1/A	[Amend] Registration statement for certain foreign private issuers

View All SEC Filings